{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:10Z","timestamp":1785196810327,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The rising prevalence of atrial fibrillation has led to increasing the numbers of pulmonary vein isolations. Optimising care pathway efficiency is essential for sustainable healthcare delivery. This study aimed to evaluate the impact of closure devices (CD) within the care pathway on hospital stay, patient satisfaction, staff workload, and costs, following catheter ablation for atrial fibrillation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study compared the standard care pathway following catheter ablation using manual compression (MC, December 2023\u2013February 2024) to a\u00a0modified pathway incorporating suture-mediated CD (March-May 2024). Primary outcomes included process indicators (e.g., hospitalisation duration), clinical outcomes (e.g., bleeding complications), and patient experience. Secondary outcomes included staff experience and healthcare costs associated with procedural changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A\u00a0total of 159 patients participated (MC: 81\u00a0patients, CD: 78\u00a0patients). Patients received an average of 2\u00a0percutaneous sutures. Treatment with CDs resulted in a\u00a03.7-hour reduction in hospitalisation duration (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&lt;. 001), 10-minute shorter procedure time in first-time ablations (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u2009.006), and 4\u2011hour shorter bed rest (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&lt;. 001). Patients experienced less pain, measured using the Numeric Rating Scale (median\u00a03 vs\u00a01,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u2009.001), and used less pain medication (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u2009.006). Discharge comfort was higher in the CD group (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u2009.009), while complication rates remained similar. 24\u00a0nurses participated in the questionnaire. Most nurses reported improved time efficiency and workday organisation. Costs were similar across groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CDs improve care pathways after atrial fibrillation ablation by reducing hospitalisation time, enhancing patient comfort, and improving workflow efficiency without increasing complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12471-026-02020-2","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:30:53Z","timestamp":1772548253000},"page":"133-142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optimising the atrial fibrillation ablation pathway using vascular closure devices: effects on length of stay, procedure time and outcomes"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0298-7705","authenticated-orcid":false,"given":"Miriam A.","family":"Scheurwater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"de Louw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"van Veghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela N.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre J.","family":"Ouss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf P. J.","family":"de Bruin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas R. C.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"2020_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100786","volume":"37","author":"D Linz","year":"2024","unstructured":"Linz\u00a0D, Gawalko\u00a0M, Betz\u00a0K, et\u00a0al. Atrial fibrillation: epidemiology, screening and digital health. Lancet Reg Health Eur. 2024;37:100786.","journal-title":"Lancet Reg Health Eur"},{"issue":"18","key":"2020_CR2","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","volume":"285","author":"AS Go","year":"2001","unstructured":"Go\u00a0AS, Hylek\u00a0EM, Phillips\u00a0KA, et\u00a0al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370\u20135.","journal-title":"JAMA"},{"issue":"5","key":"2020_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks\u00a0G, Potpara\u00a0T, Dagres\u00a0N, et\u00a0al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"1","key":"2020_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar\u00a0JA, Chung\u00a0MK, Armbruster\u00a0AL, et\u00a0al. 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e1\u2013e156.","journal-title":"Circulation"},{"issue":"1","key":"2020_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/eurheartj\/ehw260","volume":"38","author":"P Kirchhof","year":"2017","unstructured":"Kirchhof\u00a0P, Calkins\u00a0H. Catheter ablation in patients with persistent atrial fibrillation. Eur Heart J. 2017;38(1):20\u20136.","journal-title":"Eur Heart J"},{"issue":"1","key":"2020_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10840-022-01255-4","volume":"65","author":"BL Freedman","year":"2022","unstructured":"Freedman\u00a0BL, Yang\u00a0S, Shim\u00a0D, et\u00a0al. Feasibility and safety of same-day discharge and shortened bedrest after atrial fibrillation ablation. J\u00a0Interv Card Electrophysiol. 2022;65(1):209\u201317.","journal-title":"J Interv Card Electrophysiol"},{"issue":"7","key":"2020_CR7","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/europace\/euz004","volume":"21","author":"S Mohanty","year":"2019","unstructured":"Mohanty\u00a0S, Trivedi\u00a0C, Beheiry\u00a0S, et\u00a0al. Venous access-site closure with vascular closure device vs. manual compression in patients undergoing catheter ablation or left atrial appendage occlusion under uninterrupted anticoagulation: a multicentre experience on efficacy and complications. Europace. 2019;21(7):1048\u201354.","journal-title":"Europace"},{"issue":"3","key":"2020_CR8","first-page":"129","volume":"27","author":"JB Hermiller","year":"2015","unstructured":"Hermiller\u00a0JB, Leimbach\u00a0W, Gammon\u00a0R, et\u00a0al. A prospective, randomized, pivotal trial of a novel extravascular collagen-based closure device compared to manual compression in diagnostic and interventional patients. J\u00a0Invasive Cardiol. 2015;27(3):129\u201336.","journal-title":"J Invasive Cardiol"},{"issue":"1","key":"2020_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jacep.2019.08.013","volume":"6","author":"A Natale","year":"2020","unstructured":"Natale\u00a0A, Mohanty\u00a0S, Liu\u00a0PY, et\u00a0al. Venous Vascular Closure System Versus Manual Compression Following Multiple Access Electrophysiology Procedures: The AMBULATE Trial. JACC Clin Electrophysiol. 2020;6(1):111\u201324.","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"2020_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.26599\/1671-5411.2023.04.004","volume":"20","author":"JY Sun","year":"2023","unstructured":"Sun\u00a0JY, Xuan\u00a0CB, Yu\u00a0HL, et\u00a0al. Feasibility and clinical benefits of the double-ProGlide technique for hemostasis after cryoballoon atrial fibrillation ablation with uninterrupted oral anticoagulants. J\u00a0Geriatr Cardiol. 2023;20(4):268\u201375.","journal-title":"J Geriatr Cardiol"},{"issue":"7","key":"2020_CR11","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/pace.14753","volume":"46","author":"V Castro-Urda","year":"2023","unstructured":"Castro-Urda\u00a0V, Segura-Dominguez\u00a0M, Jimenez-Sanchez\u00a0D, et\u00a0al. Efficacy and safety of Proglide use and early discharge after atrial fibrillation ablation compared to standard approach. PROFA trial. Pacing Clin Electrophysiol. 2023;46(7):598\u2013606.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"4","key":"2020_CR12","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/europace\/euad022","volume":"25","author":"D Fabbricatore","year":"2023","unstructured":"Fabbricatore\u00a0D, Buytaert\u00a0D, Valeriano\u00a0C, et\u00a0al. Ambulatory pulmonary vein isolation workflow using the Perclose ProglideTM suture-mediated vascular closure device: the PRO-PVI study. Europace. 2023;25(4):1361\u20138.","journal-title":"Europace"},{"issue":"5","key":"2020_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s11606-011-1926-z","volume":"27","author":"L Fraenkel","year":"2012","unstructured":"Fraenkel\u00a0L, Falzer\u00a0P, Fried\u00a0T, et\u00a0al. Measuring pain impact versus pain severity using a numeric rating scale. J\u00a0Gen Intern Med. 2012;27(5):555\u201360.","journal-title":"J Gen Intern Med"},{"issue":"23","key":"2020_CR14","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran\u00a0R, Rao\u00a0SV, Bhatt\u00a0DL, et\u00a0al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736\u201347.","journal-title":"Circulation"},{"key":"2020_CR15","unstructured":"Open Data portal of the Dutch Healthcare Authority. Open Data portal of the Dutch Healthcare Authority. 2024. https:\/\/opendisdata.nza.nl\/."},{"key":"2020_CR16","unstructured":"CAO ziekenhuizen salary table 1\u201112-2023 Accessed on 1\u00a0December 2023 [Available from: https:\/\/cao-ziekenhuizen.nl\/]."},{"issue":"2","key":"2020_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/europace\/euaa255","volume":"23","author":"D Mol","year":"2021","unstructured":"Mol\u00a0D, Houterman\u00a0S, Balt\u00a0JC, et\u00a0al. Complications in pulmonary vein isolation in the Netherlands Heart Registration differ with sex and ablation technique. Europace. 2021;23(2):216\u201325.","journal-title":"Europace"},{"issue":"2","key":"2020_CR18","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"CT January","year":"2019","unstructured":"January\u00a0CT, Wann\u00a0LS, Calkins\u00a0H, et\u00a0al. 2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: A\u00a0Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation. 2019;140(2):e125\u2013e51.","journal-title":"Circulation"},{"issue":"10","key":"2020_CR19","first-page":"50","volume":"91","author":"M Porter","year":"2013","unstructured":"Porter\u00a0M, Lee\u00a0T. The strategy that will fix health care. Harv Bus Rev. 2013;91(10):50\u201370.","journal-title":"Harv Bus Rev"},{"key":"2020_CR20","volume-title":"Redefining Health care: creating value-based competition on results","author":"M Porter","year":"2006","unstructured":"Porter\u00a0M, Teisberg\u00a0E. Redefining Health care: creating value-based competition on results. Harvard Business School Press; 2006."},{"issue":"26","key":"2020_CR21","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMp1011024","volume":"363","author":"ME Porter","year":"2010","unstructured":"Porter\u00a0ME. What is value in health care? N Engl J Med. 2010;363(26):2477\u201381.","journal-title":"N Engl J Med"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-026-02020-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12471-026-02020-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-026-02020-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T07:03:16Z","timestamp":1774335796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12471-026-02020-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2020"],"URL":"https:\/\/doi.org\/10.1007\/s12471-026-02020-2","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.A.\u00a0Scheurwater, B.\u00a0de Louw, D.\u00a0van Veghel, D.N.\u00a0Schulz, A.J.\u00a0Ouss, R.P.J.\u00a0de Bruin and L.R.C.\u00a0Dekker declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}